Trials / Completed
CompletedNCT05402566
MRI Assessment of Impaired Glucose Metabolism in Alzheimer's Disease
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 21 (actual)
- Sponsor
- University of Aarhus · Academic / Other
- Sex
- All
- Age
- 18 Years – 85 Years
- Healthy volunteers
- —
Summary
Diseases of dementia are chronic, untreatable, and cause a massive burden of morbidity. In this proposal, we seek to tackle the problem of better, earlier, and more efficient diagnosis using deuterium metabolic imaging (DMI). The study is divided in two sub-studies: 1) optimization and simplification of DMI protocols, and 2) a cross-sectional study of DMI in Alzheimer's patients and healthy controls.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIAGNOSTIC_TEST | Deuterium metabolic imaging | MRI after oral administration of 75g of \[6,6'-2H2\]glucose. |
Timeline
- Start date
- 2022-12-22
- Primary completion
- 2023-10-27
- Completion
- 2023-10-27
- First posted
- 2022-06-02
- Last updated
- 2023-12-01
Locations
1 site across 1 country: Denmark
Source: ClinicalTrials.gov record NCT05402566. Inclusion in this directory is not an endorsement.